117 KENDRICK STREET, NEEDHAM, MA
Appoints Martine Zimmermann, PharmD, to its Board of Directors
Investor Presentation
Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Candel Therapeutics Elects Four Directors at Annual Meeting
News, Material Contracts
Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
Annual Report to Security Holders
Q2
Q1
FY 2025
Q3
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Initial Statement of Beneficial Ownership
Correspondence
Submission Upload